• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec5
Galectin Therapeutics Inc. Releases New Data on Galectin-3 Inhibitor Belapectin
21:15
Nov15
Galectin Therap released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.128 (forecast USD -0.11)
04:00
Galectin Therap released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.4015
04:00
Nov10
Galectin Therapeutics Reports Positive Results for Belapectin in MASH Liver Disease 2b Phase NAVIGATE Trial
12:57
Aug15
Galectin Therap released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.12 (forecast USD -0.16)
03:00
Galectin Therap released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.2714
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.223 M, EPS -0.128

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.584 M, EPS -0.1195

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.605 M, EPS -0.1519

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
VMAR
1.070
+181.56%
+0.700
SRXH
0.5889
+93.40%
+0.287
AMCI
12.895
+77.37%
+5.649
CPAC
10.355
+48.14%
+3.365
EDHL
0.5602
+46.80%
+0.179
RILY
5.100
+37.10%
+1.380
RZLV
3.138
+35.27%
+0.814
EEX
4.675
+32.06%
+1.135
VERO
2.190
+31.13%
+0.520
ALDX
5.120
+28.32%
+1.130
View More